RT Journal Article
SR Electronic
T1 Black bone MRI morphometry for mandibular cortical bone measurement in head and neck cancer patients: Prospective method comparison with CT
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.21.20154880
DO 10.1101/2020.07.21.20154880
A1 Joint Head and Neck MRI-Radiotherapy Development Cooperative
A1 Lisanne V. van Dijk
A1 Juan Ventura
A1 Kareem Wahid
A1 Lin L. Zhu
A1 Brigid A. McDonald
A1 Sara Ahmed
A1 Keith Sanders
A1 Sonja M. Stieb
A1 Lance McCoy
A1 Christina S. Sharafi
A1 Kathryn Preston
A1 Joly Fahim
A1 Aubryane DeArmas
A1 Mona Arbab
A1 Yao Ding
A1 Jihong Wang
A1 Bastien Rigaud
A1 Anando Sen
A1 Mark Chambers
A1 Katherine A. Hutcheson
A1 Kristy K. Brock
A1 Stephen Y. Lai
A1 Abdallah S. R. Mohamed
A1 Clifton D. Fuller
YR 2020
UL http://medrxiv.org/content/early/2020/07/26/2020.07.21.20154880.abstract
AB Objectives To determine the utility of low-flip angle “black bone” magnetic resonance imaging (MRI) for cortical mandibular bone assessment by comparing interdentium cortical measurements and inter-observer morphometric variability in relation to computed tomography (CT).Methods Quantification of cortical mandible bone width was performed as per Hamada et al. at 15 cross-sectional interdentium locations on pre-treatment black bone MRI and CT for 15 oropharyngeal cancer patients, with inter-observer analyses on a subset of 3 patients by 11 observers. Bland-Altman limits of agreement and bias estimation, Lin’s concordance correlation (LCC), and Deming orthogonal regression were used to compare CT and MRI measurements. The absolute variance and intraclass correlation coefficient (ICC) were implemented for the inter-observer error quantification.Results Both the Bland Altman and Deming regression analyses showed CT and black bone MRI measurements were comparable within ±0.85 mm limits of agreement, and systematically smaller for MRI. LCC (0.60[0.52;0.67]) showed moderate equivalence between modalities. The average absolute variance between the observers was similar on CT (1.13±0.06 mm) and MRI (1.15 ±0.06 mm). The ICC analyses showed that measurement consistency was significantly higher (p<0.001) for the black bone MRI (0.43[0.32;0.56]) than CT (0.22[0.13;0.35]); nonetheless, the ICC was poor for both modalities.Conclusions Black bone MR sequence is usable as an alternative to CT for cortical mandible bone measurements, allowing use for early detection of cortical alteration (e.g. osteonecrosis). The cortical bone measurements showed substantive but equivalent inter-observer variation on both CT and black bone MRI. (Semi)automated measurement may mitigate this in future work.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04265430Funding StatementDr. van Dijk, received/receives funding and salary support from the Dutch organization NWO ZonMw unrelated to this project during the period of study execution via the Rubicon Individual career development grant. Dr. Lai, Mohamed, and Fuller received/receives funding and salary support related to this project during the period of study execution from: the National Institutes of Health (NIH) National Institute for Dental and Craniofacial Research (NIDCR) Establishing Outcome Measures Award (R01DE025248/R56DE025248). Dr. Fuller, Mohamed, Lai, and Brock received/receives funding and salary support related to this project during the period of study execution from: the NIH NIDCR Academic Industrial Partnership Grant (R01DE028290). Dr. Hutcheson, Mohamed, Lai, and Fuller received/receives funding and salary support related to this project during the period of study execution from: the NIH National Cancer Institute (NCI) Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (R01CA218148). Mr. McCoy, Ventura and Sanders are funded by NIH Research Supplements to Promote Diversity in Health-Related Research (R01DE025248-S02, R01CA218148-S01, and R01DE028290-S01, respectively). Ms. McDonald received/receives funding and salary support unrelated to this project during the period of study execution from: the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) from NIH/NIDCR (1F31DE029093-01A1) and the Dr. John J. Kopchick Fellowship from the MD Anderson UTHealth Graduate School of Biomedical Sciences. Ms. McDonald has received travel funding and honoraria from Elekta AB unrelated to this project. Dr. Stieb is funded by the Swiss Cancer League (BIL KLS-4300-08-2017). Mr. Wahid is supported by a training fellowship from The University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences TL1 Program (Grant No. TL1 TR003169). Dr. Fuller received/receives funding and salary support unrelated to this project during the period of study execution from: an NIH/NCI Cancer Center Support Grant (CCSG) Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program (P30CA016672); an NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50 CA097007); NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute (NCI) Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA2148250); National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Programs for Residents and Clinical Fellows Grant (R25EB025787-01); National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF 1557679); NSF Division of Civil, Mechanical, and Manufacturing Innovation (CMMI) grant (NSF 1933369); and the Sabin Family Foundation. Dr. Fuller has received direct industry grant support, honoraria, and travel funding from Elekta AB unrelated to this project. Dr. Arbab received funding unrelated to this project during the period of study execution from: ACRO Resident Seed Grant Direct infrastructure support is provided to all listed investigators by the multidisciplinary Stiefel Oropharyngeal Research Fund of the University of Texas MD Anderson Cancer Center Charles and Daneen Stiefel Center for Head and Neck Cancer, and the MD Anderson NIH/NCI Cancer Center Support Grant (P30CA016672), and the MD Anderson Program in Image-guided Cancer Therapy. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was registered in the clinicaltrial.gov and approved by the local Research Ethics Committee of the MD Anderson Cancer Center (PA16-0302). A written Informed Consent Term, previously approved by the Research Ethics Committee, was obtained from all patients enrolled in this study, following the Declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMRI and CT DICOM data & measurements will be available shortly on figshare: doi:10.6084/m9.figshare.12670754 https://doi.org/10.6084/m9.figshare.12670754